Editorial: The role of omics characteristics in the diagnosis, treatment, and prognosis of autoimmune diseases

Bibliographic Details
Main Authors: Qinglong Wu, Kang Ning, Xiaoxiao Zhao, Feng Liao, Min Wang, Longgang Chang, Yanmin Liu, Jinmiao Chen, Ming Zhao, Zhangran Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.1069918/full
_version_ 1797991415363403776
author Qinglong Wu
Kang Ning
Xiaoxiao Zhao
Feng Liao
Min Wang
Min Wang
Longgang Chang
Yanmin Liu
Jinmiao Chen
Jinmiao Chen
Ming Zhao
Zhangran Chen
Zhangran Chen
Zhangran Chen
author_facet Qinglong Wu
Kang Ning
Xiaoxiao Zhao
Feng Liao
Min Wang
Min Wang
Longgang Chang
Yanmin Liu
Jinmiao Chen
Jinmiao Chen
Ming Zhao
Zhangran Chen
Zhangran Chen
Zhangran Chen
author_sort Qinglong Wu
collection DOAJ
first_indexed 2024-04-11T08:50:41Z
format Article
id doaj.art-60cb0886a8a542a384ce2b1446c3f257
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-04-11T08:50:41Z
publishDate 2022-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-60cb0886a8a542a384ce2b1446c3f2572022-12-22T04:33:34ZengFrontiers Media S.A.Frontiers in Immunology1664-32242022-11-011310.3389/fimmu.2022.10699181069918Editorial: The role of omics characteristics in the diagnosis, treatment, and prognosis of autoimmune diseasesQinglong Wu0Kang Ning1Xiaoxiao Zhao2Feng Liao3Min Wang4Min Wang5Longgang Chang6Yanmin Liu7Jinmiao Chen8Jinmiao Chen9Ming Zhao10Zhangran Chen11Zhangran Chen12Zhangran Chen13Texas Children’s Microbiome Center, Baylor College of Medicine, Houston, TX, United StatesSchool of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, ChinaShenzhen Wedge Microbiology Research Co.Ltd, Shenzhen, ChinaShenzhen Wedge Microbiology Research Co.Ltd, Shenzhen, ChinaShenzhen Wedge Microbiology Research Co.Ltd, Shenzhen, ChinaInner Mongolia Shuangqi Pharmaceutical Co.Ltd, Huhhot, ChinaShenzhen Wedge Microbiology Research Co.Ltd, Shenzhen, ChinaInner Mongolia Shuangqi Pharmaceutical Co.Ltd, Huhhot, ChinaSingapore Immunology Network (SIgN), Agency for Science, Technology and Research (ASTAR), Singapore, SingaporeImmunology Translational Research Program, Yong Loo Lin School of Medicine, Department of Microbiology and Immunology, National University of Singapore (NUS), Singapore, SingaporeThe Second Xiangya Hospital, Central South University, Changsha, ChinaShenzhen Wedge Microbiology Research Co.Ltd, Shenzhen, ChinaInner Mongolia Shuangqi Pharmaceutical Co.Ltd, Huhhot, ChinaDepartment of Gastroenterology, Zhongshan Hospital Affiliated to Xiamen University, Xiamen, Chinahttps://www.frontiersin.org/articles/10.3389/fimmu.2022.1069918/fullautoimmune diseasesbiomarkermicroRNAsfecal microbiotarheumatoid arthritisomics technology
spellingShingle Qinglong Wu
Kang Ning
Xiaoxiao Zhao
Feng Liao
Min Wang
Min Wang
Longgang Chang
Yanmin Liu
Jinmiao Chen
Jinmiao Chen
Ming Zhao
Zhangran Chen
Zhangran Chen
Zhangran Chen
Editorial: The role of omics characteristics in the diagnosis, treatment, and prognosis of autoimmune diseases
Frontiers in Immunology
autoimmune diseases
biomarker
microRNAs
fecal microbiota
rheumatoid arthritis
omics technology
title Editorial: The role of omics characteristics in the diagnosis, treatment, and prognosis of autoimmune diseases
title_full Editorial: The role of omics characteristics in the diagnosis, treatment, and prognosis of autoimmune diseases
title_fullStr Editorial: The role of omics characteristics in the diagnosis, treatment, and prognosis of autoimmune diseases
title_full_unstemmed Editorial: The role of omics characteristics in the diagnosis, treatment, and prognosis of autoimmune diseases
title_short Editorial: The role of omics characteristics in the diagnosis, treatment, and prognosis of autoimmune diseases
title_sort editorial the role of omics characteristics in the diagnosis treatment and prognosis of autoimmune diseases
topic autoimmune diseases
biomarker
microRNAs
fecal microbiota
rheumatoid arthritis
omics technology
url https://www.frontiersin.org/articles/10.3389/fimmu.2022.1069918/full
work_keys_str_mv AT qinglongwu editorialtheroleofomicscharacteristicsinthediagnosistreatmentandprognosisofautoimmunediseases
AT kangning editorialtheroleofomicscharacteristicsinthediagnosistreatmentandprognosisofautoimmunediseases
AT xiaoxiaozhao editorialtheroleofomicscharacteristicsinthediagnosistreatmentandprognosisofautoimmunediseases
AT fengliao editorialtheroleofomicscharacteristicsinthediagnosistreatmentandprognosisofautoimmunediseases
AT minwang editorialtheroleofomicscharacteristicsinthediagnosistreatmentandprognosisofautoimmunediseases
AT minwang editorialtheroleofomicscharacteristicsinthediagnosistreatmentandprognosisofautoimmunediseases
AT longgangchang editorialtheroleofomicscharacteristicsinthediagnosistreatmentandprognosisofautoimmunediseases
AT yanminliu editorialtheroleofomicscharacteristicsinthediagnosistreatmentandprognosisofautoimmunediseases
AT jinmiaochen editorialtheroleofomicscharacteristicsinthediagnosistreatmentandprognosisofautoimmunediseases
AT jinmiaochen editorialtheroleofomicscharacteristicsinthediagnosistreatmentandprognosisofautoimmunediseases
AT mingzhao editorialtheroleofomicscharacteristicsinthediagnosistreatmentandprognosisofautoimmunediseases
AT zhangranchen editorialtheroleofomicscharacteristicsinthediagnosistreatmentandprognosisofautoimmunediseases
AT zhangranchen editorialtheroleofomicscharacteristicsinthediagnosistreatmentandprognosisofautoimmunediseases
AT zhangranchen editorialtheroleofomicscharacteristicsinthediagnosistreatmentandprognosisofautoimmunediseases